TY  - JOUR 
AU  - Labrador, Jorge
AU  - Luño, Elisa
AU  - Vellenga, Edo
AU  - Brunet, Salut
AU  - González-Campos, José
AU  - Chillón, Maria C.
AU  - Holowiecka, Aleksandra
AU  - Esteve, Jordi
AU  - Bergua, Juan
AU  - González-Sanmiguel, José D
AU  - Gil, Cristina
AU  - Tormo, Mar
AU  - Salamero, Olga
AU  - Manso, Félix
AU  - Fernández, Isolda
AU  - de la Serna, Javier
AU  - Moreno, María José
AU  - Pérez Encinas, Manuel Mateo
AU  - Krsnik, Isabel
AU  - Ribera, Josep Maria
AU  - Cervera, Jose
AU  - Calasanz, María J
AU  - Boluda, Blanca
AU  - Sobas, Marta
AU  - Lowenberg, Bob
AU  - Sanz, Miguel A.
AU  - Montesinos, Pau
PY  - 2019
UR  - http://hdl.handle.net/20.500.11940/22442
AB  - [EN] Although additional cytogenetic abnormalities (ACA) do not affect the prognosis of patients with t(15;17) acute promyelocytic leukemia (APL), the role of a complex karyotype (CK) is yet to be clarified. We aimed to investigate the relationship of...
LA  - eng
KW  - Abnormal Karyotype
KW  - Prognosis
KW  - Karyotype
KW  - Arsenic Trioxide
KW  - Treatment Outcome
KW  - Humans
KW  - Drug Therapy
KW  - Cytogenetic Analysis
KW  - Leukemia, Promyelocytic, Acute
KW  - Antineoplastic Combined Chemotherapy Protocols
TI  - Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy
DO  - 10.1080/10428194.2018.1522438
T2  - Leukemia & Lymphoma
M2  - 1146
KW  - ATRA
KW  - CHUS
VL  - 60
ER  -